Clinical impact of the Alzheimer's Disease Neuroimaging Initiative: A review of studies using ADNI data (2023 to June 2025) - PubMed
5 hours ago
- #Biomarkers
- #Neuroimaging
- #Alzheimer's Disease
- The Alzheimer's Disease Neuroimaging Initiative (ADNI) provides a comprehensive open-access dataset integrating neuroimaging, biomarker, genetic, and clinical data.
- From 2023 to mid-2025, about 1830 publications used ADNI data, highlighting studies with direct clinical applications.
- ADNI data has impacted the development of plasma biomarkers, improved clinical trials, and advanced methods for diagnosis and prediction in Alzheimer's disease.
- The review underscores ADNI's role in enhancing understanding of disease progression and accelerating translational research toward individualized patient care.